ZYGMONT CHESTER STANLEY III (Chief Financial Officer) received a stock award from REVELATION BIOSCIENCES, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/13/2025ACC: 0000950170-25-020104
Officer· Chief Financial Officer
Since Jan 2022
+15.05K
Net shares
Net buyer
$58.2K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
15.05K acquired
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+15.05K
Price / share
$3.87
Trade value
$58.24K
% of position
53742.9%
2/11/2025
28.00→15.08K
Total
Net shares
+15.05K
Net value
$58.24K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 2/11/2025 | A · Award | +15.05K | $3.87 | $58.24K | 53742.9% | 28.00 | 15.08K |
| Total | +15.05K | $58.24K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned28.00
Common Stock
IndirectShares owned13.00
Total
41.00 indirect41.00
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 28.00 | Indirect |
| Common Stock | 13.00 | Indirect |
| Total | 41.00 | 41.00 indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported